Wayne Koberstein
-
Companies To Watch: AMO Pharma
8/2/2021
AMO Pharma is applying “de-risked” compounds as potential medicines for rare diseases in brain development.
-
Companies To Watch: NervGen Pharma
7/1/2021
NervGen Pharma is going beyond preclinicals to human trials for a drug that could repair and regrow neurons.
-
The Collective Benefits Of A Collaborative CFO
7/1/2021
Terry Coelho, CFO, works as a team member, not just a finance manager, at BioDelivery Sciences.
-
Coming Out Of Stealth Mode: What To Know And Do
7/1/2021
Five CEOs discuss their experiences with stealth mode transitions. They address when and how a company should turn away from that introspective state and show itself to the world.
-
Companies To Watch: IM Therapeutics
6/1/2021
Our company to watch this month is IM Therapeutics, which focuses on developing small molecule therapies for Type 1 diabetes, celiac disease, and other autoimmune conditions.
-
Synergistic COVID Therapy Development
5/3/2021
From the outside, it may look as if Biophytis took a sharp turn from its focus on aging to address Covid. But look again.
-
Companies To Watch: Lyra Therapeutics
5/3/2021
Our company to watch this month, Lyra Therapeutics, is focused on controlling chronic ENT conditions with precise drug elution and long action.
-
180 Life Sciences: Deliberately Seeking Serendipity
4/1/2021
At 180 Life Sciences, veterans of the old-pharma world are building a small bio enterprise focused evenly on scientific and market opportunities in the inflammation space.
-
Companies To Watch: Carisma Therapeutics
4/1/2021
Carisma Therapeutics is a private company developing CAR-M (chimeric antigen receptor macrophage) as an alternative to CAR-T (CAR-T cell) and potential treatment for solid tumors rather than just liquid cancers.
-
Canadian COVID Vax Comes Forward
3/1/2021
Long before the Warp Speed race, vaccines were a global business more characterized by collaboration than competition. In concert with its national regulator, Health Canada, IMV, Inc. could make world history with its approach to COVID vaccination.